Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.048 | 0.8 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |